Literature DB >> 18095266

Tumor size: a non-neglectable independent prognostic factor for gastric cancer.

Xi Wang1, Fei Wan, Jun Pan, Guan-Zhen Yu, Ying Chen, Jie-Jun Wang.   

Abstract

BACKGROUND AND OBJECTIVES: The role of tumor size should not be neglected in the management of gastric cancer and its prognostic value needs precise reevaluation.
METHODS: The survival data of 513 patients who underwent radical resection between 2000 and 2005 were collected retrospectively. Tumor size, measured as the maximum diameter of tumor, was categorized into four subgroups (< or =2, < or =3, < or =5, >5 cm) using the method of minimizing the estimated average expected distance (AED) objective function. The prognostic value of tumor size and the correlation between tumor size and other clinicopathologic factors were investigated.
RESULTS: In multivariate analysis, status of lymph nodes (P < 0.001), depth of invasion (P < 0.001), type of resection (P = 0.004), age (P = 0.008), tumor size (P = 0.014), and perioperative blood transfusion (P = 0.034) were confirmed as independent prognostic predictors for patients with gastric cancer. Log linear model suggested that the status of lymph nodes and the depth of invasion associated with the tumor size significantly.
CONCLUSIONS: The tumor size is a non-neglectable independent prognostic factor for patients with gastric cancer and more attention should be paid to its role in the management of gastric cancer. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Year:  2008        PMID: 18095266     DOI: 10.1002/jso.20951

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  27 in total

1.  Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer.

Authors:  Jeonghun Kim; Seok Tae Lim; Chang Ju Na; Yeon-Hee Han; Chan-Young Kim; Hwan-Jeong Jeong; Myung-Hee Sohn
Journal:  Nucl Med Mol Imaging       Date:  2013-11-28

2.  Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection.

Authors:  Jeong Won Lee; Sang Mi Lee; Moon-Soo Lee; Hyeong Cheol Shin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-07       Impact factor: 9.236

3.  Role of tumor size in the pre-operative management of rectal cancer patients.

Authors:  Inti Zlobec; Parham Minoo; Eva Karamitopoulou; George Peros; Efstratios S Patsouris; Frank Lehmann; Alessandro Lugli
Journal:  BMC Gastroenterol       Date:  2010-06-15       Impact factor: 3.067

4.  lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis.

Authors:  Chunjing Xu; Yongfu Shao; Tian Xia; Yunben Yang; Jiawei Dai; Lin Luo; Xinjun Zhang; Weiliang Sun; Haojun Song; Bingxiu Xiao; Junming Guo
Journal:  Tumour Biol       Date:  2014-06-27

5.  Prognostic value of tumor size in gastric cancer: an analysis of 2,379 patients.

Authors:  Pengtao Guo; Yangming Li; Zhi Zhu; Zhe Sun; Chong Lu; Zhenning Wang; Huimian Xu
Journal:  Tumour Biol       Date:  2013-01-15

6.  Clinicopathologic characteristics and outcomes of surgery of middle-third gastric cancer.

Authors:  Jingyu Deng; Han Liang; Rupeng Zhang; Dan Sun; Yi Pan; Li Zhang; Xishan Hao
Journal:  Tumour Biol       Date:  2012-08-07

7.  Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.

Authors:  Hong-Mei Wang; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

8.  Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.

Authors:  Jian-Hui Chen; Shi-Rong Cai; Er-Tao Zhai; Si-Le Chen; Kai-Ming Wu; Wu Song; Yu-Long He
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Clinicopathologic features of gastric carcinoma with signet ring cell histology.

Authors:  Ming Zhang; Guanyu Zhu; Hongfeng Zhang; Hongyu Gao; Yingwei Xue
Journal:  J Gastrointest Surg       Date:  2009-12-22       Impact factor: 3.452

Review 10.  Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis.

Authors:  Fausto Petrelli; Michele Ghidini; Antonio Ghidini; Giovanni Sgroi; Ivano Vavassori; Daniela Petrò; Mary Cabiddu; Alberto Aiolfi; Gianluca Bonitta; Alberto Zaniboni; Emanuele Rausa
Journal:  Surg Today       Date:  2021-01-03       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.